Sign inJoin waitlistJoin the waitlist

Scott Cotler

Division Director, Hepatology · Loyola University Medical Center

Credentials: · · · · ·

History

Loyola University Medical Center
Present

Transplant Hepatology
1996–1997
Gastroenterology
University of Washington School of Medicine
1995–1996
Gastroenterology
Rush University Medical Center
1993–1995
Internal Medicine
University of Chicago Medical Center
1990–1993
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
1986–1990

Research

Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life
Proceedings of the National Academy of Sciences of the United States of America · 2013 · 263 citations
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
The Lancet Infectious Diseases · 2015 · 210 citations
Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?
Case report · Archives of Pathology & Laboratory Medicine · 2008 · Last of 6 authors · 149 citations

TL
Thomas Layden
26 papers
Eric Kallwitz
21 papers · 12 as a fellow
Donald Jensen
20 papers
OE
Ohad Etzion
14 papers
Xianzhong Ding
10 papers
Jamie Berkes
9 papers
Enrico Benedetti
8 papers
AG
Ashish Goyal
7 papers
James Bui
7 papers
Miguel Malespin
7 papers · 3 as a fellow
Natasha Von Roenn
7 papers · 1 as a fellow
Robert Carithers
7 papers

Clinical trials

Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
Principal investigator · Terminated · Phase 2
University of Illinois at Chicago
2006–2010